BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹13,992 Cr | ₹18,959 Cr | ₹17,603 Cr | ₹16,086 Cr | ₹6,827 Cr |
What is the latest Profit & Loss Account Balance ratio of BIOCON ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹13,992 Cr |
| Mar2025 | ₹18,959 Cr |
| Mar2024 | ₹17,603 Cr |
| Mar2023 | ₹16,086 Cr |
| Mar2022 | ₹6,827 Cr |
How is Profit & Loss Account Balance of BIOCON Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,992 Cr | -26.20 | |
| Mar2025 | ₹18,959 Cr | 7.71 | |
| Mar2024 | ₹17,603 Cr | 9.43 | |
| Mar2023 | ₹16,086 Cr | 135.61 | |
| Mar2022 | ₹6,827 Cr | - | |
Compare Profit & Loss Account Balance of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹60,461.9 Cr | -4.1% | -8.4% | 5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -4.1% |
-8.4% |
5.3% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses